Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib

Lynn Quek, Muriel D David, Alison Kennedy, Marlen Metzner, Michael Amatangelo, Alan Shih, Bilyana Stoilova, Cyril Quivoron, Maël Heiblig, Christophe Willekens, Véronique Saada, Samar Alsafadi, M S Vijayabaskar, Andy Peniket, Oliver A Bernard, Sam Agresta, Katharine Yen, Kyle MacBeth, Eytan Stein, George S VassiliouRoss Levine, Stephane De Botton, Anjan Thakurta, Virginie Penard-Lacronique, Paresh Vyas

Research output: Contribution to journal › Article › peer-review

138 Citations (Scopus)
90 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology